Study Links Xanthelasma to Increased Risk of Heart Attacks and Strokes
Atherosclerosis, characterized by the buildup of fatty plaques in arteries, is a leading cause of heart attacks and strokes. Often developing silently over time, it can lead to serious medical emergencies without prior symptoms. In light of this, researchers are actively seeking early warning signs of atherosclerosis to help in early detection and prevention. A recent study published in the journal Atherosclerosis focuses on xanthelasma, a condition marked by yellow patches that appear around the eyes. These patches occur when immune cells, known as macrophages, accumulate cholesterol and fats. Xanthelasma is frequently associated with elevated blood cholesterol levels, prompting researchers at Stanford University to investigate a potential link between this condition and cardiovascular risks. The study, led by Stanford ophthalmology researcher Negin Yavari, involved analyzing health data from 17,925 individuals diagnosed with xanthelasma, compared to a control group of the same size with presbyopia, a common age-related vision condition. The analysis revealed that within the first year, 1% of participants with xanthelasma experienced a heart attack, compared to 0.35% in the control group. The incidence of strokes was also higher among those with xanthelasma, with rates of 0.95% versus 0.3% in controls. Though these percentages are relatively low, the risk for those with xanthelasma was significantly elevated. Over time, while the gap in risk between the two groups narrowed, individuals with xanthelasma continued to show a substantially higher risk of cardiovascular events at both the five- and ten-year marks. The researchers concluded that xanthelasma is associated with a higher incidence of major cardio-cerebrovascular events (MACCEs), suggesting its potential role as a clinical marker for assessing cardiovascular risk and guiding preventive management. Interestingly, the incidence rates of heart attacks and strokes were similar among those with xanthelasma, regardless of whether they had high levels of fat in their blood, indicating that other underlying factors may contribute to this increased risk. While the yellow patches themselves are generally considered harmless, the findings underscore their potential significance as indicators of cardiovascular health. The researchers advocate for increased awareness among dermatologists, who often see patients for cosmetic reasons, to consider underlying cardiovascular risk factors in those presenting with xanthelasma. They suggest that screening for heart health issues in these individuals could lead to timely lifestyle modifications or medical interventions, ultimately preventing serious cardiovascular events. Future research may delve deeper into the reasons behind the heightened risk of heart attacks and strokes in patients with xanthelasma, providing further insights into the development of cardiovascular diseases. Regular monitoring and management by primary care physicians are recommended to implement preventive strategies, including lifestyle changes and treatment for high blood pressure or cholesterol. This study highlights the importance of evaluating patients with xanthelasma early to identify and manage any systemic health conditions that could lead to serious cardiovascular events.




